News
Media
PodcastsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Richard H. Lee, MD

Advertisement

Articles by Richard H. Lee, MD

Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy

ByThe Society for Maternal-Fetal Medicine (SMFM),Richard H. Lee, MD,Mara Greenberg, MD,Torri D. Metz, MD,Christian M. Pettker, MD
June 8th 2021

Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters of pregnancy and is characterized by pruritus and elevated serum bile acid concentrations.

Advertisement

Latest Updated Articles

  • Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy
    Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy

    Published: June 8th 2021 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Top 5 women's health headlines you missed in October 2025

2

FDA approves fosfomycin for treating cUTIs

3

FDA grants IDE approval for FemBloc non-surgical permanent birth control

4

Elective egg freezing on the rise, but few patients return to use preserved oocytes

5

Researchers identify 4 distinct PCOS subtypes to guide treatment

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us